Such observational data are subject to confounding by indication for the prescription of such medications although the effect of renin-angiotensin system inhibition cannot be attributed to comorbidities, such as hypertension, which were of a similar frequency between patient cohorts. This evidence concerns the gene REN and hypertensive disorder.